Last reviewed · How we verify
CT-guided corticosteroid+ bupivicaine
A CT-guided injection combining a corticosteroid and local anesthetic to reduce inflammation and provide pain relief at a targeted anatomical site.
A CT-guided injection combining a corticosteroid and local anesthetic to reduce inflammation and provide pain relief at a targeted anatomical site. Used for CT-guided injection for inflammatory lesions or joint pain, Localized pain and inflammation management.
At a glance
| Generic name | CT-guided corticosteroid+ bupivicaine |
|---|---|
| Sponsor | Montefiore Medical Center |
| Drug class | Corticosteroid + local anesthetic combination injection |
| Modality | Small molecule |
| Therapeutic area | Pain Management / Rheumatology / Interventional Medicine |
| Phase | FDA-approved |
Mechanism of action
Corticosteroids suppress inflammatory responses by inhibiting cytokine production and immune cell activation, while bupivacaine is a local anesthetic that blocks nerve conduction. When delivered together via CT guidance to a specific lesion or joint, this combination provides both anti-inflammatory and analgesic effects with high anatomical precision.
Approved indications
- CT-guided injection for inflammatory lesions or joint pain
- Localized pain and inflammation management
Common side effects
- Injection site pain or discomfort
- Transient local swelling
- Infection at injection site
- Systemic corticosteroid effects (with repeated use)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: